Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease
Status:
Completed
Trial end date:
2019-11-08
Target enrollment:
Participant gender:
Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in
20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin
D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing
cancer, heart disease, and stroke in people who do not have a prior history of these
illnesses. This ancillary study is being conducted among participants in VITAL with a history
of diabetes and will examine whether vitamin D or fish oil prevents the development and
progression of diabetic kidney disease.
Phase:
N/A
Details
Lead Sponsor:
University of Washington
Collaborators:
Brigham and Women's Hospital National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins